10.08.2011 • News

Synthes H1 Profit Rises

Synthes posted higher six-month net earnings of $454.37 million compared with $424.59 million last year. Half-yearly earnings per share improved to €3.83 from €3.58 a year earlier.

Net sales increased to $1.97 billion from $1.80 billion in the comparable period.

First-half 2011 gross profit margin of 82.5% remained strong and was in-line with the previous year of 82.4%, as continued pricing pressures were mitigated by ongoing operational improvements, the company added.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.